Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors?

European Urology

Volumn 59, Issue 3, 2011, Pages 374-376

  Oosterlinck, Willem ^a   Sylvester, Richard ^a   Babjuk, Marco ^a   Kaasinen, Eero ^a   Böhle, Andreas ^a   Palou Redorta, Juan ^a   Rouprêt, Morgan ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPIRUBICIN; GEMCITABINE;

BLADDER TUMOR; CANCER GRADING; CAUTERIZATION; CYSTOSCOPY; DRUG INSTILLATION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MENTAL STRESS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; TRANSURETHRAL RESECTION; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; HUMANS; PRACTICE GUIDELINES AS TOPIC; URINARY BLADDER NEOPLASMS;

EID: 79551482259     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.12.002     Document Type: Editorial

References (13)

1. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314
2. M.A. Brausi Challenging the EAU guidelines on non-muscle-invasive bladder cancer (NMIBC): single instillation of chemotherapy after transurethral resection of NMIBC and chemotherapy versus bacillus Calmette-Guérin in treatment of intermediate-risk tumours Eur Urol Supp 9 2010 406 410
3. J. Dobruch, and H. Herr Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection? BJU Int 104 2009 170 174
4. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190 quiz 2435
5. W. Oosterlinck, K.H. Kurth, F. Schroder, J. Bultinck, B. Hammond, and R. Sylvester A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder J Urol 149 1993 749 752
6. P. Rajala, E. Kaasinen, M. Raitanen, T. Liukkonen, and E. Rintala Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study - FinnBladder III long-term results J Urol 168 2002 981 985
7. I. Berrum-Svennung, T. Granfors, S. Jahnson, H. Boman, and S. Holmang A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences J Urol 179 2008 101 105 discussion 105-6
8. S. Gudjónsson, L. Adell, and F. Merdasa Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study Eur Urol 55 2009 773 780
9. A. Böhle, H. Leyh, and C. Frei Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study Eur Urol 56 2009 495 503
10. T. Cai, G. Nesi, and G. Tinacci Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study J Urol 180 2008 110 115
11. K. Hendricksen, W.P.J. Witjes, and J.G. Idema Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer Eur Urol 53 2008 984 991
12. E. Kaasinen, E. Rintala, and P. Hellström Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma Eur Urol 42 2002 167 174
13. R.J. Sylvester, W. Oosterlinck, and J.A. Witjes The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials Eur Urol 53 2008 709 719